Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Adding today:
Feb 22, 2017 Buy LXX 2,500.00 0.491 Feb 27, 2017 68168946
Investment -1,237.45 USD
DescriptionLEXARIA BIOSCIENCE CORP COM
That was rude
Just need the right deal to catch the right group of investors...
Nite bidder is soft, why not just slap 54s and fill?
There is SO much infringement on our patent in the legal and non-legal markets in both Canada and USA already. Look for results to come from NRC study and then acquisition by big pharma or MJ company with the $ to start pursuing litigation against those profiting from our patented technology IMVHO
The CBD, yes. THC, no. More info on the pages now though.
Something in the works here, TurboCBD:
https://trademarks.justia.com/871/42/turbocbd-87142224.html
Statements
Goods and Services
Dietary and nutritional supplements; hemp oil infused herbal and vitamin dietary and nutritional supplements; dietary and nutrition supplements in capsule form and in liquid form; all of the foregoing containing CBD
Wow CSTI DONKEY alert
ARCA was main MM on bid when we ran last time, ever since he been on ask... I anticipate he switches sides again shortly once news drops
I guess for those still accumulating ARCA is kind of giving out gifts... I'm just ready to RUMBA and hate watching him poop at parties
Need ARCA off the ask, he's being a real POS undercutting asks and whacking bids... POS if u wanna know how I feel lol
Generally PRs are wired through a newswire service, and the outlets that pick up the news choose to
That they did, this round is pathetic. Paying someone to make a few Tweets when they were already pumping us pre-contract could have been better played. This news is huge long term today.
Decent volume, where's the whales at? Didn't we just sign a new awareness contract?
Lexaria Bioscience (LXRP, CNSX:LXX) Rubs Elbows With Some Impressive Names
Lexaria Bioscience Corp (OTCMKTS:LXRP, CNSX:LXX) has inked a development deal with none other than the Canadian government's top research division... and the government is chipping in some money.
By Bryan Murphy
Feb 8, 2017 7:10:25 AM PST | No Comment(s) - Post a Comment Rating
Print Email
StockHQ:
LXRP $0.55 +$0.04 +7.84%
You can tell a lot about a company by the company it keeps. That's why the news from Lexaria Bioscience Corp (OTCMKTS:LXRP, CNSX:LXX) should turn heads. The organization is teaming up with the National Research Council of Canada (NRC) to further develop its bioavailability science. It's a big -- and telling -- deal simply because with the National Research Council of Canada is "the Government of Canada's premier research and technology organization (RTO)." Not a bad friend to have.
Of course, given the science Lexaria Bioscience has developed, news of a master collaborative research agreement comes as no real surprise.
For those not familiar with it, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, though Lexaria is starting with hemp as it's the most underserved market and arguably the biggest growth opportunity.
The game-changer is that Lexaria Bioscience is able to combine whatever molecules it wants with lipids -- or fatty acids -- at the molecular level. It matters, because the human endocannabinoid system is itself lipid based, making this format the easiest and most effective means of introducing vitamins, minerals, medicines, and more.
The science works, too - two different studies have been done to support the claim.
The first study -- a third party review and in-vitro assessment of cannabidiol (CBD) bioabsorption done late last year -- indicated up to a 499% improvement in absorption compared to what was currently achievable. The second study performed earlier this year was a human clinical trial of nitric oxide induction. This study demonstrated potent CBD bioabsorption in humans using a nitricoxide salivary biomarker test. All subjects demonstrated rapid, significant and sustained increase in salivary nitric oxide levels (a 500%-1000% increase) following product ingestion.
Others have taken notice, and become interested in seeing just how far the proprietary science can go. The National Research Council of Canada is one of those that's taken interest, including financially. It's committed $125,00 (matching Lexaria's contribution)to " investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions." The collaboration will investigate and define the chemical nature of the molecular association that Lexaria`s patented technology is believed to effectuate between lipophilic active agents and fatty acids as solubility and bioavailability enhancing agents. Effective delivery of lipophilic active agents spans across industry sectors such as, food, vitamins, pharmacy and more, which are multi-billion dollar opportunities.
Lexaria Bioscience believes this research -- and the partnership itself -- will ultimately lead to more licensing agreements. It's not a bad assumption either. The non-profit NCR lends a lot of credibility to the work Lexaria has done to date.
For more on Lexaria, visit the company website here.
Lol, no doubt.
Just took a starter, anyone got L2 snapshot? on the road.
Lexaria Bioscience (LXRP) is Porfectly-Positioned as Hemp Becomes Mainstream
Lexaria Bioscience Corp (OTCMKTS:LXRP) to start the mainstreaming of hemp, by improving its benefit right when the benefit becomes clear.
By Matthew Briar
Feb 6, 2017 6:34:07 AM PST | No Comment(s) - Post a Comment Rating
inShare
Share
Print Email
StockHQ:
NU.V $0.14 -$0.01 -3.57% LXRP $0.52 $0.00 0.00%
Contrary to popular belief, hemp and marijuana aren't the same thing. The difference between hemp and marijuana is primarily the amount of tetrahydrocannabinol (or THC), or is the primary psychoactive chemical in marijuana. Hemp contains less than 0.5% THC, while marijuana consists of anywhere from 6 % to 20% (and sometimes more) THC.
Granted, it's not always a fully-appreciated distinction. Even though the federal government accurately recognizes that hemp and marijuana are only variants of the same species, Cannabis sativa, the DEA doesn't necessarily enforce its drug laws as such. For legitimate medical purposes, the government is perfectly willing to leave the matter alone.
The good news is, governments - federal as well as state - are finally starting to figure out the distinct differences between marijuana and hemp, and that bodes well for a young and hungry startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).
In simplest terms, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.
You may not know it, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don't actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn't extracted, but rather passes right through. Not only is it a waste of time and money, it's a bit of a hassle to swallow a big capsule (or several capsules) for little to no benefit.
Lexaria Bioscience changes all of this. Simply put, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it's the most underserved market and arguably the biggest growth opportunity.
Hemp seeds (which are technically a nut and are also known as "hemp hearts") are rich in healthy fats, protein, and minerals. They promote heart health and skin health, and are an excellent source of nutrition. Specifically, they contain high amounts of the amino acid arginine, which is used to produce nitric oxide in the body Nitric oxide is a gas molecule that makes the blood vessels dilate and relax, leading to lowered blood pressure and a reduced risk of heart disease. Hemp seeds are a also great source of polyunsaturated and essential fatty acids. They have about a 3:1 ratio of omega-6 to omega-3, which is considered in the optimal range.
Studies have shown using hemp seed oil may improve blood levels of essential fatty acids, which fights eczema. It may also relieve dry skin and decrease itchiness.
The key, however, is the science. Lexaria Bioscience is able to combine cannabinoids with lipids -- or fatty acids -- at the molecular level. It matters, as the human endocannabinoid system is itself lipid based, making this format the easiest and most effective means of introducing the medicinal and health benefits of hemp and hemp oil.
Its business model is two-fold. It licenses its hemp-infused oil to distributors of cannabis edibles, and it makes its own retail brand of hemp-based products. Its brand names are ViPova(tm) and Lexaria Energy Foods. The former is a brand of teas, coffee and hot chocolate, and the latter (so far) is a mix of protein bars and the like.
Indeed, it's also garnered interest from business partners. In November, Lexaria Bioscience and NeutriSci International Inc (CVE:NU) jointly announced they were entering a joint venture that would utilize Lexaria Bioscience's proprietary infusion platform and tap into NeutriSci International's existing distribution network to create and market a whole new supplement product line. In January, the duo announced it had finalized new supplement that is done testing and will soon be available for consumers. The tablet (a 'melt', technically) is a combination of pterostilbene and cannabidiol, offering a double-barreled benefit to the health-conscious.
It's exciting simply because NeutriSci International has an established name and marketing channel, while Lexaria Bioscience has the science that makes hemp oil far more functional.
And that's just one partner/venue. Lexaria's already got other revenue lined up. See, it's been establishing partnerships since May of this year to provide its hemp-oil-infused food platform to distributors/retailers and edibles suppliers. Some of the details on some of these deals weren't disclosed. On others, they were, and the opportunity for several million dollars in annual royalty revenue is already on the table. (Royalty revenue is easy, high-margin revenue.) And that's before Lexaria could turn up the heat with the confidence of the patent it was awarded late last year... the patent on the process used to improve the absorbability of its hemp oil. With that protection in hand, the company can really turn up the heat.
At stake is a piece of the $6 billion edible cannabis market, and that's just one market. As was noted, the same know-how has an application in improving the absorption potential of medicines, health supplements, painkillers, nicotine (for smoking cessation), and more.
Investors looking for a speculative off-the-radar idea that could make it big may want to take a long hard look at LXRP.
For more on Lexaria, visit the company website here.
3 MMs under .57 EOM
Feb 3, 2017 Buy LXX 2,500.00 0.465 Feb 8, 2017
Investment -1,172.45 USD
Description LEXARIA BIOSCIENCE CORP COM
I am at .465
I'd say this takedown was a gap fill IMO I'd look for move back up from here...
Nice, it's always encouraging to see longs stick with something they believe in and reap the rewards... I could trade here, but not worth the headache IMO.
half a million bought today so far
Smart money is sitting at .45 with the other smart money
Oh snap, get your bids in for when this ETRF donkey whacks the rest of his load, up time after that IMO!
Jeez, look at these ask monkeys
This is a product sold by a Licensed Producer here in Canada: https://www.tilray.ca/en/products/tilray-products/tilray-cbd-drops-11/
I am thinking once our patent is accepted in Canada there will be some dues to pay!
One big NITE seller keeps popping up with big asks and scaring out all the KIDS IMO
I'm a dip adder, regardless of how many I have :) Right now have several in that gap in case our OG Neb is correct...
All retail MMs on the ask, the usual suspects know better and all sitting $1+. No toxics, no excessive dilution. Winner. $LXRP
Aren't you curious how much the licensing fee is for this one?
https://www.sec.gov/Archives/edgar/data/1348362/000106299316011663/exhibit10-1.htm
It could be bigger than we even realize.
I always look at CBDS for comparison... they hold a patent application on a STRAIN of high CBD MJ (which will never happen, for same reason wine companies can't patent a grape). Now look at their cap:
Share Structure
Market Value1 $136,712,580 a/o Jan 31, 2017
Authorized Shares 45,000,000 a/o Oct 30, 2015
Outstanding Shares 18,474,673 a/o Nov 14, 2016
With insiders DUMPING shares: http://www.otcmarkets.com/stock/CBDS/insider-transactions
LXRP has approved patent, and a bag full of patents pending on tech that could disrupt the industry. Now look at are cap:
Share Structure
Market Value1 $30,967,937 a/o Jan 31, 2017
Authorized Shares 220,000,000 a/o Nov 30, 2016
Outstanding Shares 55,299,888 a/o Jan 11, 2017
Insiders only buying: http://www.otcmarkets.com/stock/LXRP/insider-transactions
I'll just leave this here to let sink in...
I feel like Lexaria's technology will be highly sought after soon as most LPs in Canada are already offering CBD/THC suspsended in Lipophalic lipids like oils seen here: https://www.tilray.ca/en/products/tilray-products/tilray-cbd-drops-31/
Someone caught wind right at close ;)
NITE and CDEL selling fake shares IMO lol
Looks like they released the whacken